GL1X · GenesisL1 explorer

Research workbench

Ebola virus VP35 bound to small molecule

Analyse Ebola virus VP35 bound to small molecule in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4IBE
Type
protein
Length
247 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Polymerase cofactor VP35
UniProt
Q05127
Ligands
11Y
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolymerase cofactor VP35protein12352% helix, 13% strandQ05127
BPolymerase cofactor VP35protein12450% helix, 13% strandQ05127

Ligands and binding sites

  • 11Y · 5-[(2R)-3-benzoyl-2-(4-bromothiophen-2-yl)-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl]-2-chlorobenzoic acid · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19060.710.766511Y

Interfaces

1 interface between chains.

  • A–B · 270 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 4IBE · Ebola virus VP35 bound to small molecule · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.